Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial P

Haque, T. et al. (2007) Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial P. Blood, 110(4), pp. 1123-1131. (doi: 10.1182/blood-2006-12-063008)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1182/blood-2006-12-063008

Abstract

We present the results of a multicenter clinical trial using Epstein-Barr virus (EBV)–specific cytotoxic T lymphocytes (CTLs) generated from EBV-seropositive blood donors to treat patients with EBV-positive posttransplantation lymphoproliferative disease (PTLD) on the basis of the best HLA match and specific in vitro cytotoxicity. Thirty-three PTLD patients who had failed on conventional therapy were enrolled. No adverse effects of CTL infusions were observed and the response rate (complete or partial) in 33 patients was 64% at 5 weeks and 52% at 6 months. Fourteen patients achieved a complete remission, 3 showed a partial response, and 16 had no response at 6 months (5 died before completing treatment). At 5 weeks, there was a significant trend toward better responses with higher numbers of CD4<sup>+</sup> cells in infused CTL lines (<i>P</i> = .001) that were maintained at 6 months (<i>P</i> = .001). Patients receiving CTLs with closer HLA matching responded better at 6 months (<i>P</i> = .048). Female patients responded better than male patients, but the differences were not statistically significant. Our results show that allogeneic CTLs are a safe and rapid therapy for PTLD, bypassing the need to grow CTLs for individual patients. The response rate in this poor prognosis patient group is encouraging.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McAulay, Dr Karen
Authors: Haque, T., Wilkie, G.M., Jones, M.M., Higgins, C.D., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., Amlot, P.L., Kelly, D., MacGilchrist, A., Gandhi, M.K., Swerdlow, A.J., and Crawford, D.H.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Blood
ISSN:0006-4971
ISSN (Online):1528-0020
Published Online:27 April 2007

University Staff: Request a correction | Enlighten Editors: Update this record